Maelstrom Research Staging | RECOVER_Phase_2_COVID19_subgroup_365_days_post_dose

RECOVER_Phase_2_COVID19_subgroup_365_days_post_dose_1

Networks -

Variables -

Associated study RECOVER Contingency Table

Population

RECOVER - Phase 2 COVID-19 subgroup

The population is composed of healthcare workers who participated in the first phase of the RECOVER study and will receive a COVID-19 vaccine. The first vaccine dose is administered around 8.4 ± 2.3 months (range: 0.8-13.1 months) after a PCR-confirmed SARS-CoV-2 infection. The second dose is offered 16 ± 6 weeks after the first dose.

Selection Criteria

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Participants must have had a PCR-confirmed COVID-19 infection prior to enrollment.

Participants included in this study are selected based on their reported symptomatology at the time of infection and their serostatus at enrollment in the study.

Other Criteria

Participants must be healthcare workers from phase 1 of the RECOVER study. They are selected if their blood samples are available before and after vaccination.

Supplementary Information about selection criteria

Symptomatic participants are matched with asymptomatic participants based on their sex, age, ethnicity, and times of infection and vaccination.

Recruitment

Sources of recruitment

Participants from existing studies

Supplementary Information

Participants are recruited from the Phase 1 COVID-19 group of the RECOVER study.

Participants from Existing Studies

REinfection in COVID-19 Estimation of Risk (RECOVER)

Number of Participants

Number of Participants: 25
Number of Participants with Biological Samples: 25
Supplementary Information about selection criteria

More info

Data Collection Event

RECOVER - Phase 2 COVID-19 subgroup - 12 months post dose 1

Information is collected about underlying medical conditions and known risk factors (hypertension, diabetes, chronic pulmonary conditions, pregnancy, etc.), new flu-like illnesses (including the symptomatology), medications prescribed in the last 6 months, hospitalizations and treaments, history of vaccinations, and vitamin intake. Blood samples are collected.

More info

Collected Dataset / RECOVER_Phase_2_COVID19_subgroup_365_days_post_dose_1

RECOVER_Phase_2_COVID19_subgroup_365_days_post_dose_1

Population

RECOVER - Phase 2 COVID-19 subgroup

Data Collection Event

RECOVER - Phase 2 COVID-19 subgroup - 12 months post dose 1

Files

Variables Classifications